A Randomized, Double-Blind, Placebo-Controlled, Cross-Over, Safety, Tolerability and Proof of Concept Study of ST101 for Essential Tremor.

Trial Profile

A Randomized, Double-Blind, Placebo-Controlled, Cross-Over, Safety, Tolerability and Proof of Concept Study of ST101 for Essential Tremor.

Completed
Phase of Trial: Phase II

Latest Information Update: 05 Jan 2012

At a glance

  • Drugs ST 101 (Primary)
  • Indications Essential tremor
  • Focus Adverse reactions; Therapeutic Use
  • Most Recent Events

    • 05 Jan 2012 Actual patient number (25) added as reported by ClinicalTrials.gov.
    • 05 Jan 2012 Status changed from recruiting to completed as reported by ClinicalTrials.gov.
    • 19 Aug 2011 Planned end date changed from 1 Oct 2011 to 1 Dec 2011 as reported by ClinicalTrials.gov.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top